With integrated, insight‑driven platforms that cut through data complexity and eliminate fragmented workflows, Instem empowers researchers to reduce risk, boost efficiency, and accelerate the journey from discovery to IND submission.
NAMs have the potential to deliver more efficient safety assessments, enabling faster and more confident development decisions while also supporting more ethical drug development.
Every breakthrough begins with a single molecule. Follow the journey from early research to regulatory submission and learn how Instem helps teams work more efficiently, reduce risk, and deliver safer, more effective therapies to patients...
Instem is reaffirming its role as the industry’s trusted provider of an end-to-end preclinical platform.
The latest release introduces advanced features to enhance toxicity prediction, improve data integration, and support in silico safety assessments.
The Society of Toxicology (SOT) 2025 Annual Meeting was an incredible experience for Instem, with packed sessions, insightful discussions, and exciting new connections.
